Healthcare and life sciences companies need capital that understands long development timelines, regulation and the difference between a promising product and a business. Family offices are increasingly willing to provide it.
Who invests
Family offices with a healthcare interest or background
Private investors using the Enterprise Investment Scheme for qualifying companies
Specialist healthcare funds and corporate venture arms
Secondary buyers providing liquidity to early shareholders
What investors look for
Clinical or commercial evidence that the product works and people will pay for it
A clear regulatory path and the cost of getting there
Intellectual property the company owns
A team with experience of taking products to market
How much capital is needed to reach the next value point
Preparing a raise
Investors move faster when the information is ready: a short summary, a full plan, a data room and a realistic valuation.
Our record
Our Health and Wellness work, led by Kingsley Wilson, includes introducing co investors to Secondary Capital on its purchase of shares in Alto Pharmacy, a leading US digital pharmacy.
To discuss a raise, call James Innes on 020 7850 4760 or email james.innes@chrystalcapital.com.
This article is general information and is not advice.